Instituto de Investigación Biomédica da Coruña (INIBIC): Envíos recentes
Mostrando ítems 71-75 de 809
-
Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis
(Elsevier, 2020-07)[Abstract] Objective: To draft recommendations on interleukin 6 (IL-6) blockade in rheumatoid arthritis (RA), based on best evidence and experience. Methods: A group of 10 experts on IL-6 blockade in RA was selected. ... -
Assessing the relationship between molecular rejection and parenchymal injury in heart transplant biopsies
(Wolters Kluwer, 2022-11)[Abstract] Background: The INTERHEART study (ClinicalTrials.gov #NCT02670408) used genome-wide microarrays to detect rejection in endomyocardial biopsies; however, many heart transplants with no rejection have late dysfunction ... -
Proteomic profiling of human menisci from mild joint degeneration and end-stage osteoarthritis versus healthy controls
(Elsevier, 2023-12)[Abstract] Objective. To gain new insight into the molecular changes of the meniscus by comparing the proteome profiles of healthy controls with mild degeneration and end-stage osteoarthritis (OA). Method. We obtained ... -
The consequences of the COVID‐19 pandemic for self‐care in patients supported with a left ventricular assist device
(European Society of Cardiology, 2020-06) -
International Consortium for Health Outcomes Measurement (ICHOM): standardized patient-centered outcomes measurement set for heart failure patients
(American College of Cardiology Foundation, 2020-03)[Abstract] Whereas multiple national, international, and trial registries for heart failure have been created, international standards for clinical assessment and outcome measurement do not currently exist. The working ...